Michelle S Pearson Selected Research

1- (2,3- dichlorobenzoyl)- 5- methoxy- 2- methyl- (2- (mopholin- 4- yl)ethyl)- 1H- indole

12/2005	A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
4/2005	Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michelle S Pearson Research Topics

Disease

3	Pain (Aches) 09/2006 - 04/2005
3	Inflammation (Inflammations) 04/2005 - 08/2004
3	Hyperalgesia 04/2005 - 08/2004
2	Ataxia (Dyssynergia) 12/2005 - 04/2005
2	Catalepsy 12/2005 - 04/2005
2	Chronic Pain 12/2005 - 04/2005
1	Neuralgia (Stump Neuralgia) 09/2006
1	Postoperative Pain 08/2004

Drug/Important Bio-Agent (IBA)

2	1- (2,3- dichlorobenzoyl)- 5- methoxy- 2- methyl- (2- (mopholin- 4- yl)ethyl)- 1H- indoleIBA 12/2005 - 04/2005
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 12/2005 - 04/2005
2	CB2 Cannabinoid ReceptorIBA 12/2005 - 04/2005
1	pyrimidineIBA 09/2006
1	Lamotrigine (Lamictal)FDA LinkGeneric 09/2006
1	Carbamazepine (Tegretol)FDA LinkGeneric 09/2006
1	Sodium Channel BlockersIBA 09/2006
1	Analgesics (Analgesic Drugs)IBA 12/2005
1	CannabinoidsIBA 12/2005
1	Cannabinoid Receptor AgonistsIBA 04/2005
1	Adenosine Triphosphate (ATP)IBA 11/2004
1	AcidsIBA 11/2004
1	A-317491IBA 11/2004
1	mu Opioid Receptors (mu Opioid Receptor)IBA 08/2004
1	Naltrexone (ReVia)FDA LinkGeneric 08/2004
1	Opioid Analgesics (Opioids)IBA 08/2004

Therapy/Procedure

1	Ligation 09/2006
1	Therapeutics 09/2006
1	Analgesia 04/2005